147 related articles for article (PubMed ID: 18445949)
1. Diagnosing different stages of hepatitis B infection using a competitive polymerase chain reaction assay.
Changotra H; Dwivedi A; Nayyar AK; Sehajpal PK
Indian J Med Microbiol; 2008; 26(2):138-42. PubMed ID: 18445949
[TBL] [Abstract][Full Text] [Related]
2. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
[TBL] [Abstract][Full Text] [Related]
3. Serum hepatitis B virus (HBV) DNA levels at different stages of clinical course in patients with chronic HBV infection in an endemic area.
Heo J; Baik TH; Kim HH; Kim GH; Kang DH; Song GA; Cho M; Yang US
J Korean Med Sci; 2003 Oct; 18(5):686-90. PubMed ID: 14555821
[TBL] [Abstract][Full Text] [Related]
4. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
5. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.
Assy N; Beniashvili Z; Djibre A; Nasser G; Grosovski M; Nseir W
World J Gastroenterol; 2009 Jun; 15(24):3025-31. PubMed ID: 19554656
[TBL] [Abstract][Full Text] [Related]
6. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.
Lindh M; Horal P; Dhillon AP; Norkrans G
J Viral Hepat; 2000 Jul; 7(4):258-67. PubMed ID: 10886534
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.
Atay AE; Seven G; Yalcin K; Pasa S; Degertekin H
J Int Med Res; 2012; 40(5):1891-6. PubMed ID: 23206472
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
[TBL] [Abstract][Full Text] [Related]
10. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
Chu CJ; Hussain M; Lok AS
Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
[TBL] [Abstract][Full Text] [Related]
11. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
[TBL] [Abstract][Full Text] [Related]
12. Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.
Shen T; Wu WM; Du WH; Wang L; He G; Tan L; Wang Z; Chen R; Hu M; Ren YP
Lipids Health Dis; 2016 Dec; 15(1):210. PubMed ID: 27927202
[TBL] [Abstract][Full Text] [Related]
13. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
[TBL] [Abstract][Full Text] [Related]
15. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay.
Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Valdes A; Galimany R; Esteban R; Guardia J
J Viral Hepat; 2001 Nov; 8(6):465-71. PubMed ID: 11703579
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
[TBL] [Abstract][Full Text] [Related]
17. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
[TBL] [Abstract][Full Text] [Related]
19. Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?
Sali S; Sharafi H; Alavian SH; Alavian SM; Etesam F; Salimi S; Merza MA; Keshvari M
Diagn Microbiol Infect Dis; 2015 Jun; 82(2):114-9. PubMed ID: 25863529
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection.
Tan Z; Li M; Kuang X; Tang Y; Fan Y; Deng G; Wang Y; He D
J Clin Virol; 2014 Apr; 59(4):228-34. PubMed ID: 24529415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]